Evotec Stock
WKN 566480 | ISIN DE0005664809

Quote

  Bid Ask
Quote 21,83 21,865
Units 150 Units 138 Units
current/rel. spread 0,035 0,160%
Quote time 18/10/2017 21:59:58
Daily high/low (money) 22,128 21,38
Change compared with
previous day (bid)
0,285 +1,32%
Last quote of the day 21,83 21,865

Price data

Stock exchange Stuttgart  
Last 21,83G 0 Units
Price determination time 18/10/2017 20:10:24
Daily volume (Units) 25.606  
Daily high/low 22,01 21,38
Prev. day's price (17/10) 21,583  
Change day before +0,25 +1,14%
Yearly high/low 22,58 (04/10) 6,69 (08/02)
52 week high / low 22,58 (04/10) 4,70 (09/11)

Latest quotes

Quote time Bid Ask
18/10/2017 / 21:59:58 21,83 21,865
18/10/2017 / 21:59:55 21,83 21,866
18/10/2017 / 21:59:50 21,83 21,865
18/10/2017 / 21:59:48 21,83 21,864
18/10/2017 / 21:59:27 21,83 21,863
18/10/2017 / 21:59:26 21,83 21,861
Historical quotes on Evotec

Key performance figures

  1 week 1 month 3 months 1 year 3 years 5 years
Performance +8,33% +16,89% +65,22% +332,28% +709,12% +637,50%
Rel. performance onEurostoxx 50 +7,32% +13,88% +60,60% +311,85% +683,20% +589,79%
Rel. performance onTecDAX +7,22% +10,87% +54,03% +289,43% +588,96% +425,60%

Video

NEWS AUS DEM HANDEL 3:07min, 10. Oktober 2017, 10:38 Uhr

Evotec Key figures

  2017e 2016 2015 2014
PER 57,35 37,21 32,08 -
Earnings per share 0,38 0,20 0,13 -0,05
Dividend 0,00 0,00 0,00 0,00
Dividend yield in % 0,00 0,00 0,00 0,00

Additional key figures on Evotec

Evotec Master data

WKN 566480
ISIN DE0005664809
Symbol EVT
Exchange segment Open Market
Type of financial instrument Stock
Denomination EVOTEC
Index membership TecDAX CDAX KURSINDEX
Trading segment -
Trading hours 8 - 22 Uhr
Currency EUR
Sector and industry Chemical/Pharmaceutical/Health - Biotechnology
Number of shares 147.494.037
Market capitalisation 3,21 Mrd.

Evotec Peer group

Name WKN Price Change / previous day
STELLAR BIOTECHNOLOG.. A14ZWQ 1,023 +36,58%
BQE WATER INC A2DMQV 0,042 +31,25%
ENDOCYTE INC. A1H68U 4,27 +19,11%
SUNWIN STEVIA INTERN.. A1JXDL 0,078 +18,18%
AVITA MEDICAL LTD. A0Q40S 0,040 +17,65%
AMPLIPHI BIOSCIENCES.. A2DQXA 1,136 +16,63%

Evotec Corporate events

Date Corporate event
08/11/2017 Veröffentlichung Quartalsmitteilung (Stichtag Q3) Evotec AG

Evotec in the profile

Evotec is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists. We operate worldwide providing the highest quality stand-alone and integrated drug discovery solutions, covering all activities from target-to-clinic. The Company has established a unique position by assembling top-class scientific experts and integrating state-of-the-art technologies as well as substantial experience and expertise in key therapeutic areas including neuroscience, pain, metabolic diseases as well as oncology, inflammation and infectious diseases. Evotec has long-term discovery alliances with partners including Bayer, Boehringer Ingelheim, CHDI, Genentech, Janssen Pharmaceuticals, MedImmune/AstraZeneca, Roche and UCB. In addition, the Company has existing development partnerships and product candidates both in clinical and..

More information about Evotec can be found in the profile